233 related articles for article (PubMed ID: 15618927)
1. Expression of CD10 in basal cell carcinoma.
Yada K; Kashima K; Daa T; Kitano S; Fujiwara S; Yokoyama S
Am J Dermatopathol; 2004 Dec; 26(6):463-71. PubMed ID: 15618927
[TBL] [Abstract][Full Text] [Related]
2. Glioma-Associated Oncogene-1 Expression in Basal Cell Carcinoma and Its Histologic Mimics.
Gradecki SE; Eid MV; Pramoonjago P; Wick MR
Am J Dermatopathol; 2021 Sep; 43(9):637-641. PubMed ID: 33264133
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of CD10 and Bcl2 expression in distinguishing cutaneous basal cell carcinoma from squamous cell carcinoma and seborrheic keratosis.
Gaballah MA; Ahmed RA
Pathol Res Pract; 2015 Dec; 211(12):931-8. PubMed ID: 26573127
[TBL] [Abstract][Full Text] [Related]
4. Expression of epidermal stem cell markers in skin and adnexal malignancies.
Quist SR; Eckardt M; Kriesche A; Gollnick HP
Br J Dermatol; 2016 Sep; 175(3):520-30. PubMed ID: 26914519
[TBL] [Abstract][Full Text] [Related]
5. GREM1 is expressed in the cancer-associated myofibroblasts of basal cell carcinomas.
Kim HS; Shin MS; Cheon MS; Kim JW; Lee C; Kim WH; Kim YS; Jang BG
PLoS One; 2017; 12(3):e0174565. PubMed ID: 28346486
[TBL] [Abstract][Full Text] [Related]
6. Bcl-2 and CD10 expression in the differential diagnosis of trichoblastoma, basal cell carcinoma, and basal cell carcinoma with follicular differentiation.
Córdoba A; Guerrero D; Larrinaga B; Iglesias ME; Arrechea MA; Yanguas JI
Int J Dermatol; 2009 Jul; 48(7):713-7. PubMed ID: 19570076
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression of D2-40 in benign and malignant sebaceous tumors and comparison to basal and squamous cell carcinomas.
Yang HM; Cabral E; Dadras SS; Cassarino DS
Am J Dermatopathol; 2008 Dec; 30(6):549-54. PubMed ID: 19033927
[TBL] [Abstract][Full Text] [Related]
8. CD10, TDAG51, CK20, AR, INSM1, and Nestin Expression in the Differential Diagnosis of Trichoblastoma and Basal Cell Carcinoma.
Leblebici C; Bambul Sığırcı B; Kelten Talu C; Koca SB; Huq GE
Int J Surg Pathol; 2019 Feb; 27(1):19-27. PubMed ID: 29938548
[TBL] [Abstract][Full Text] [Related]
9. p63 expression in normal skin and usual cutaneous carcinomas.
Reis-Filho JS; Torio B; Albergaria A; Schmitt FC
J Cutan Pathol; 2002 Oct; 29(9):517-23. PubMed ID: 12358808
[TBL] [Abstract][Full Text] [Related]
10. Frequent TLE1 Expression in Cutaneous Neoplasms.
Xiong Y; Dresser K; Cornejo KM
Am J Dermatopathol; 2019 Jan; 41(1):1-6. PubMed ID: 30608261
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical comparison of cutaneous lymphadenoma, trichoblastoma, and basal cell carcinoma: support for classification of lymphadenoma as a variant of trichoblastoma.
McNiff JM; Eisen RN; Glusac EJ
J Cutan Pathol; 1999 Mar; 26(3):119-24. PubMed ID: 10235376
[TBL] [Abstract][Full Text] [Related]
12. Cytokeratin profile in basal cell carcinoma.
Alessi E; Venegoni L; Fanoni D; Berti E
Am J Dermatopathol; 2008 Jun; 30(3):249-55. PubMed ID: 18496426
[TBL] [Abstract][Full Text] [Related]
13. Comparison of EMA,CEA, CD10 and Bcl-2 Biomarkers by Immunohistochemistry in Squamous Cell Carcinoma and Basal Cell Carcinoma of the Skin.
Ramezani M; Mohamadzaheri E; Khazaei S; Najafi F; Vaisi-Raygani A; Rahbar M; Sadeghi M
Asian Pac J Cancer Prev; 2016; 17(3):1379-83. PubMed ID: 27039776
[TBL] [Abstract][Full Text] [Related]
14. Sebaceoma and related neoplasms with sebaceous differentiation: a clinicopathologic study of 30 cases.
Misago N; Mihara I; Ansai S; Narisawa Y
Am J Dermatopathol; 2002 Aug; 24(4):294-304. PubMed ID: 12142607
[TBL] [Abstract][Full Text] [Related]
15. Perilipin and adipophilin expression in sebaceous carcinoma and mimics.
Boussahmain C; Mochel MC; Hoang MP
Hum Pathol; 2013 Sep; 44(9):1811-6. PubMed ID: 23642680
[TBL] [Abstract][Full Text] [Related]
16. Trichoblastoma arising within an apocrine poroma.
Santos-Briz A; Rodríguez-Peralto JL; Miguélez A; López-Ríos F
Am J Dermatopathol; 2002 Feb; 24(1):59-62. PubMed ID: 11803284
[TBL] [Abstract][Full Text] [Related]
17. CD10 expression in trichoepithelioma and basal cell carcinoma.
Pham TT; Selim MA; Burchette JL; Madden J; Turner J; Herman C
J Cutan Pathol; 2006 Feb; 33(2):123-8. PubMed ID: 16420307
[TBL] [Abstract][Full Text] [Related]
18. Differential diagnostic significance of epithelial and stromal CD10 expression in tumors of trichogenic origin.
Kneitz H; Fetzer S; Goebeler M; Bröcker EB
J Dtsch Dermatol Ges; 2018 Jun; 16(6):719-728. PubMed ID: 29873924
[TBL] [Abstract][Full Text] [Related]
19. Distinct expression profile of stem cell markers, LGR5 and LGR6, in basaloid skin tumors.
Jang BG; Lee C; Kim HS; Shin MS; Cheon MS; Kim JW; Kim WH
Virchows Arch; 2017 Mar; 470(3):301-310. PubMed ID: 28070642
[TBL] [Abstract][Full Text] [Related]
20. CD-10 immunostaining differentiates superficial basal cell carcinoma from cutaneous squamous cell carcinoma.
Wagoner J; Keehn C; Morgan MB
Am J Dermatopathol; 2007 Dec; 29(6):555-8. PubMed ID: 18032951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]